Related by context. Frequent words. (Click for all words.) 65 heavily pretreated 63 EGFR mutations 61 cytotoxic chemotherapy 61 malignant pleural mesothelioma 61 pheochromocytoma 61 unresectable 61 secondary hyperparathyroidism 60 metastatic renal cell carcinoma 60 chronic HBV infection 60 stable angina 60 metastatic hormone refractory 59 mycophenolate mofetil 59 HER2 positive metastatic breast 59 refractory multiple myeloma 59 non squamous 59 epithelial ovarian cancer 58 cabazitaxel 58 virologic failure 58 KRAS mutations 58 XELOX 58 androgen deprivation 58 nucleoside analogue 58 atopic 58 angiotensin converting enzyme inhibitors 58 pancreatic NET 58 lymph node involvement 58 calcineurin inhibitors 58 superficial bladder cancer 58 chronic HCV 58 RRMS patients 58 DMARD 58 medullary thyroid cancer 57 resistant ovarian cancer 57 confidence interval #.#-#.# 57 % CI #.#-#.# [007] 57 severe renal impairment 57 vinorelbine 57 DOXIL 57 squamous 57 comorbidities 57 adenocarcinomas 57 relapsing MS 57 vandetanib 57 malignant lesions 57 dacarbazine 57 lipid lowering therapy 56 renal impairment 56 chlorambucil 56 lymph node metastases 56 leukopenia 56 HRPC 56 thromboembolic events 56 Amrubicin 56 Bevacizumab 56 poorer prognosis 56 seliciclib 56 pertuzumab 56 Voreloxin 56 neoplastic 56 neoadjuvant therapy 56 invasive fungal infections 56 nonresponders 56 ADHF 56 relapsed refractory multiple myeloma 56 DMARDs 56 histologically 56 HER2 negative 56 breast carcinoma 56 grade gliomas 56 bladder cancers 56 recurrent ovarian cancer 56 plus gemcitabine 56 PsA 55 biologic therapy 55 decitabine 55 PCa 55 acute coronary syndromes ACS 55 advanced NSCLC 55 multivariate analyzes 55 neoplasms 55 comorbid conditions 55 EGFR inhibitors 55 therapeutic regimens 55 azacitidine 55 veltuzumab 55 temsirolimus 55 brain metastases 55 androgen independent 55 virologic response 55 fibrinolysis 55 liver metastases 55 liver transplant recipients 55 NSCLC 55 hypercalcemia 55 chemoradiotherapy 55 OPAXIO 55 NYHA class 55 distant metastasis 55 lupus nephritis 55 SHPT 55 neoadjuvant chemotherapy